SLC6A3 and Parkinson disease: Accuracy of the clinical diagnosis of PD was achieved through ongoing follow-up visits in both cohorts as well as dopamine transporter (DAT) scanning of all enrolled patients in PPMI, thereby permitting robust group classification with the elimination of false positives as well as reliable algorithm assessment.